XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.80

-0.1%

Nov 21 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (16982)	7/3/2004 1:46:49 AM
From: Bluegreen	Read Replies (1) of 17367

Bob, one thing a physician has to do is FULLY INFORM a patient of the risks involved. If a physician FULLY informed the patient about possible risks of MS and Enbrel how could there be a case? Did the physician discuss other treatment options in regard to Psoriasis? That is the DUTY of the physician. That DUTY is owed. IF there is a BREACH of that DUTY then it turns on causation and damages. As far as the manufacturers are concerned THEIR DUTY is to FULLY INFORM also among a list of other DUTIES. Lawyers DO NOT have an easy task BUT they certainly can win a TON of money IF people are not FULLY INFORMED of the risks involved. Fully informed also means information from the treating physician about other SAFER treatment options. My point has ALWAYS revolved around FULLY INFORMED of the risks AND OTHER TREATMENT OPTIONS AVAILABLE. You know as well as I do that properly informed patients will probably choose Raptiva first over Enbrel based on safety AND you only get stuck ONCE a week instead of twice with Enbrel. Even the manufacturer was probably SHOCKED at how fast the physicians were in handing out ENBREL hence the HUGE shortage of it in the beginning. Not long ago it seemed like almost EVERYONE with a weight problem was taking FEN-PHEN. All it takes is ONE big judgement in those Enbrel cases already filed and you are off to the races with possible class action status type lawsuits. Putting a wheel chair bound MS patient in front of a jury is a VERY SCARY thought. Mealey's is the GOLD STANDARD in these types of cases and if they are doing a DEBUT on the ant-tnf meds.......that means there is probably BOTH smoke and fire. Just seeing Mealy's getting a publication out gets me thinking of shorting Amgen and Wyeth. Nothing whips up tobacco and Fen-Phen cashed up litigators more than a Mealey's analysis. So, who in the world can argue about lawyers requiring that patients are FULLY INFORMED by both manufacturers and physicians? Doesn't mean Enbrel use is being dictated by lawyers or it can't be used. It just means that the patient must be FULLY informed of the risks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next